The airway neurogenic inflammation: Clinical and pharmacological implications

Inflammation and Allergy - Drug Targets

Volumn 8, Issue 3, 2009, Pages 176-181

  Pisi, Giovanna ^a   Olivieri, Dario ^a   Chetta, Alfredo ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Asthma; COPD; Neurogenic inflammation

Indexed keywords

ACETYLCHOLINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIASTHMATIC AGENT; AVE 5883; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCITONIN GENE RELATED PEPTIDE; CROMONE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE; FUROSEMIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE RECEPTOR; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; NARCOTIC ANALGESIC AGENT; NERVE GROWTH FACTOR; NEUROKININ A; NEUROPEPTIDE Y; NEUROTROPHIN; NITRIC OXIDE; NORADRENALIN; PEPTIDE HISTIDINE METHIONINE; SUBSTANCE P; TACHYKININ DERIVATIVE; TACHYKININ RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

ADRENERGIC SYSTEM; ALLERGIC DISEASE; ASTHMA; BRONCHOSPASM; BRONCHUS MUCOSA; CAPACITANCE BLOOD VESSEL; CHOLINERGIC NERVE; CHOLINERGIC SYSTEM; EXTRAVASATION; HEMATOPOIETIC CELL; HUMAN; IMMUNOCOMPETENT CELL; LEUKOCYTE MIGRATION; NEGATIVE FEEDBACK; NERVE CELL PLASTICITY; NEUROGENIC INFLAMMATION; NONADRENERGIC NONCHOLINERGIC NERVE; NONMYELINATED NERVE; NOSE CONGESTION; NOSE MUCOSA; PLEURA FLUID; RESPIRATORY FUNCTION; RESPIRATORY TRACT DISEASE; REVIEW; VASCULARIZATION; VASOCONSTRICTION; VASODILATATION; ANIMAL; BRONCHUS; INNERVATION; METABOLISM; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA;

ANIMALS; ASTHMA; BRONCHI; HUMANS; NEUROGENIC INFLAMMATION; NEUROTRANSMITTER AGENTS; PARASYMPATHETIC NERVOUS SYSTEM; RESPIRATORY MUCOSA; SYMPATHETIC NERVOUS SYSTEM;

EID: 70349308334     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152809788681047     Document Type: Review

References (63)

1. Demello, D.E.; In Bronchial vascular remodelling in asthma and COPD; Aili Lazaar, Ed.; Informa Healthcare USA: New York, 2006; pp. 1-23.
2. Wilson, J. The bronchial microcirculation in asthma. Clin. Exp. Allergy, 2000, 30, 51-53.
3. Chetta, A.; Zanini, A.; Torre, O.; Olivieri, D. Vascular remodelling and angiogenesis in asthma: morphological aspects and pharmacological modulation. Inflamm. Allergy Drug Targets, 2007, 6, 41-45.
4. Laitinen, L.A.; In The airways. Neural control in health and diseas;. Michael A. Kaliner and Peter J Barnes, Eds.; Marcel Dekker USA: New York, 1988, pp 35-56.
5. Widdicombe, J. The physiology of the nose. Clin. Chest Med., 1986, 7, 159-170.
6. Cauna, N. In: The nose: Upper Airway Physiology and the Atmospheric Environment; Donald F. Proctor & I Andersen, Eds.; Elsevier Biomedical Press B.V.: Amsterdam, 1982, pp. 45-69.
7. Corfield, D.R.; Webber, S.E.; Widdicombe, J.G. Distribution of blood flow in the perfused tracheae of sheep: a search for arteriovenous anastomoses. J. Appl. Physiol., 1993, 74, 1856-1861.
8. Grevers, G.; Hermann, U. Fenestrated endothelia in vessels of the nasal mucosa: an electron microscopic study in the rabbit. Arch Otolaryngol., 1987, 244, 55-60.
9. Persson, C.G.A. Plasma exudation and asthma. Lung, 1988, 166, 1-23.
10. Widdicombe, J. Why are the airways so vascular? Thorax, 1993, 48, 290-295.
11. Wagner, E.M. In: The lung: Scientific Foundations; Crystal, R.G.; West, J.B.; Weibel, E.R.; Barnes, P.J.; Eds., 2nd ed.; Lippincott-Raven: Philadelphia, 1997, pp. 1093-1105.
12. Deffebach, M.E.; Charan, N.B.; Lakshminarayan, S.; Butler, J. The bronchial circulation. Small, but a vital attribute of the lung. Am. Rev. Respir. Dis., 1987, 135, 463-481.
13. Widdicombe, J. The airway vasculature. Exp. Physiol., 1993, 78, 433-452.
14. Kuwano, K.; Bosken, C.H.; Pare, P.D.; Bai, T.R.; Wiggs, B.R.; Hogg, J.C. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 1993, 148, 1220-1225.
15. White, M.V. Muscarinic receptors in human airways. J. Allergy Clin. Immunol., 1995, 95, 1065-1068.
16. Zaagsma, J.; Roffel, A.F.; Meurs, H. Muscarinic control of airways function. Life Sci., 1997, 60, 1061-1068.
17. Wasicko, M.J.; Leiter, J.C.; Erlichman, J.S.; Strobel, R.J.; Bartlett, D. Nasal and pharyngeal resistance after topical mucosal vasoconstriction in normal humans. Am. Rev. Respir. Dis., 1991, 144, 1048-1052.
18. Lacroix, J.S.; Anggård, A.; Hökfelt, T.; O'Hare, M.M.; Fahrenkrug, J.; Lundberg, J.M. Neuropeptide Y: presence in sympathetic and parasympathetic innervation of the nasal mucosa. Cell Tissue Res. 1990, 259, 119-128.
19. Spina, D.; Rigby, P.J.; Paterson, J.W.; Goldie, R.G. α1-adrenoceptor function and autoradiographic distribution in human asthmatic lung. Br. J. Pharmacol., 1989, 97, 701-708.
20. Lacroix, J.S.Adrenergic and non-adrenergic mechanisms in sympathetic vascular control of the nasal mucosa. Acta Physiol. Scand., 1989, 581, 1-63.
21. Druce, H.M.; Bonner, R.F.; Patow, C.; Choo, P.; Summers, R.J.; Kaliner, M.A. Response of nasal blood flow to neurohormones as measured by laser-Doppler velocimetry. J. Appl. Physiol., 1984, 57, 1276-1283.
22. Carstairs, J.R.; Nimmo, A.J.; Barnes, P.J. Autoradiographic visualization of β-adrenoceptor subtypes in human lung. Am. Rev. Respir. Dis., 1985, 132, 541-547.
23. McLean, J.; Mathews, K.; Ciarkowski, A.; Brayton, P.R.; Solomon, R.W. The effects of topical saline and isoproterenol on nasal airway resistance. J. Allergy Clin. Immunol., 1976, 58, 563-574.
24. Mullol, J.; Raphael, G.D.; Lundgren, J.D.; Baraniuk, J.N.; Mérida, M.; Shelhamer, J.H.; Kaliner, M.A. Comparison of human nasal mucosal secretion in vivo and in vitro. J. Allergy Clin. Immunol., 1992, 89, 584-592.
25. Barnes, P.J.; Baraniuk, J.N.; Belvisi, M.G. Neuropeptides in the respiratory tract. Part II. Am. Rev. Respir. Dis., 1991, 144, 1391-1399.
26. Lacroix, J.S.; Ulman L.G.; Potter, E.K. Sympathetic and parasymphatetic interaction in vascular control of the nasal mucosa in anesthetized cats. J. Physiol., 1994, 480, 325-331.
27. Baraniuk, J.N.; Druce, H.M. In Inflammatory mechanisms in asthma; Holgate S.T. & Busse W.W., Eds; Marcel Dekker: New York, USA, 1998, pp. 619-637.
28. Widdicombe, J.G. Autonomic regulation. I-NANC/e-NANC. Am. J. Respir. Crit. Care Med., 1998, 158, 171-175.
29. Richardson, J.B. Noradrenergic inhibitory innervation of the lung. Lung, 1981, 159, 315-322.
30. Belvisi, M.G.; Ward, J.K.; Mitchell, J.A.; Barnes, P.J. Nitric oxide as a neurotransmitter in human airways. Arch Int. Pharmacodyn. Ther., 1995, 32, 97-110.
31. Ricciardolo, F.L.; Sterk P.J.; Gaston, B.; Folkerts, G.N. Nitric oxide in health and disease of the respiratory system. Physiol. Rev., 2004, 84, 731-765.
32. Barnes, P.J.; Baraniuk, J.N.; Belvisi, M.G. Neuropeptides in the respiratory tract. Part I. Am. Rev. Respir. Dis., 1991, 144, 1187-1198.
33. Leys, K.; Morice, A.H.; Madonna O.; Sever, P.S. Autoradiographic localisation of VIP receptors in human lung. FEBS Lett., 1986, 199, 198-202.
34. Joos, G.; Kips, J.; Pauwels, R.; Van der Straeten, M. The respiratory effects of neuropeptides. Eur. J. Respir. Dis., 1986, Supll. 144, 107-136.
35. Rogers, D.F. Motor control of airway goblet cells and glands. Respir. Physiol., 2001, 125, 129-144.
36. Widdicombe, J.G. The NANC system and airway vasculature. Arch Int. Pharmacodyn. Ther., 1990, 303, 83-99.
37. Stretton, D. Non-adrenergic, non-cholinergic neural control of the airways. Clin. Exp. Pharmacol. Physiol., 1991, 18, 675-684.
38. Barnes, P.J. Asthma as an axon reflex. Lancet, 1986, 1, 242-245.
39. Solway, J.; Leff, A.R. Sensory neuropeptides and airway function. J. Appl. Physiol., 1991, 71, 2077-2087.
40. Nockher, W.A.; Renz H. Neurotrophins and asthma: Novel insight into neuroimmune interaction. J. Allergy Clin. Immunol., 2006, 117, 67-71.
41. Kirchmair, R.; Marksteiner, J.; Troger, J.; Mahata, S.K.; Mahata, M.; Donnerer, J.; Amann, R.; Fischer-Colbrie, R.; Winkler, H.; Saria, A. Human and rat primary C-fibre afferents store and release secretoneurin, a novel neuropeptide. Eur. J. Neurosci., 1994, 6, 861-868.
42. Frossard, N.; Advenier, C. Tachykinin receptors and the airways. Life Sci., 1991, 49, 1941-1953.
43. Canning, B.J. Neurokinin3 receptor regulation of the airways. Vasc. Pharmacol., 2006, 4, 227-234.
44. Barnes, P.J. Neurogenic inflammation in the airways. Respir. Physiol., 2001, 125, 145-154.
45. Murai, M.; Maeda, Y.; Hagiwara, D.; Miyake, H.; Ikari, N.; Matsuo, M.; Fujii, T. Effects of an NK1 receptor antagonist, FK888, on constriction and plasma extravasation induced in guinea pig airway by neurokinins and capsaicin. Eur. J. Pharmacol., 1993, 236, 7-13.
46. Frossard, N.; Barnes, J. Effect of tachykinins in small human airways. Neuropeptides, 1991, 19, 157-161.
47. Di Maria, G.U.; Bellofiore, S.; Geppetti, P. Regulation of airway neurogenic inflammation by neutral endopeptidase. Eur. Respir. J., 1998, 12, 1454-1462.
48. Palmer, J.B.; Cuss, F.M.; Mulderry, P.K.; Ghatei, M.A.; Springall, D.R.; Cadieux, A.; Bloom, S.R.; Polak, J.M.; Barnes, P.J. Calcitonin gene-related peptide is localized to human airway nerves and potently constricts human airway smooth muscle. Br. J. Pharmacol., 1987, 91, 95-101.
49. Mak, J.C.; Barnes, P.J. Autoradiographic localization of calcitonin gene-related peptide (CGRP) binding sites in human and guinea pig lung. Peptides, 1988, 9, 957-963.
50. Springer, J.; Geppetti, P.; Fischer, A.; Groneberg, D.A. Calcitonin gene-related peptide as inflammatory mediator. Pulm. Pharmacol. Ther., 2003, 16, 121-130.
51. Renz, H. Neurotrophins in bronchial asthma. Respir. Res., 2001, 2, 265-268.
52. Jornot L.; Lacroix J.S.; Rochat T. Neuroendocrine cells of nasal mucosa are a cellular source of brain-derived neurotrophic factor. Eur. Respir. J., 2008, 32, 769-774.
53. Schinder, A.F.; Poo, M. The neurotrophin hypothesis for synaptic plasticity. Trends Neurosci., 2000, 23, 639-645.
54. Levi-Montalcini, R.; Dal Toso, R.; della Valle, F.; Skaper, S.D.; Leon, A. Update of the NGF saga. J. Neurol. Sci., 1995, 130, 119-127.
55. Leon, A.; Buriani, A.; Dal Toso, R.; Fabris, M.; Romanello, S.; Aloe, L.; Levi-Montalcini, R. Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. USA, 1994, 91, 3739-3743.
56. Ehrhard, P.B.; Erb, P.; Graumann, U.; Otten, U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. USA, 1993, 90, 10984-10988.
57. Nockher, W.A.; Renz H. Neurotrophins in inflammatory lung diseases: modulators of cell differentiation and neuroimmune interactions. Cytokine Growth Factor Rev., 2003, 14, 559-578.
58. Raap, U.; Fokkens, W.; Bruder, M.; Hoogsteden, H.; Kapp, A.; Braunstahl, G.J. Modulation of neurotrophin and neurotrophin receptor expression in nasal mucosa after nasal allergen provocation in allergic rhinitis. Allergy, 2008, 63, 468-475
59. Jackson, D.M.; Norris, A.A.; Eady, R.P. Nedocromil sodium and sensory nerves in the dog lung. Pulm. Pharmacol., 1989, 2, 179-184.
60. Nichol, G.M.; Alton, E.W.; Nix, A.; Geddes, D.M.; Chung, K.F.; Barnes, P.J. Effect of inhaled furosemide on metabisulfite- and methacholine-induced bronchoconstriction and nasal potential difference in asthmatic subjects. Am. Rev. Respir. Dis., 1990, 142, 576-580.
61. Belvisi, M.G.; Stretton, C.D.; Verleden, G.M.; Ledingham, S.J.; Yacoub, M.H.; Barnes, P.J. Inhibition of cholinergic neurotransmission in human airways by opioids. J. Appl. Physiol., 1992, 72, 1096-1100.
62. Joos, G.F.; De Swert, K.O.; Schelfhout, V.; Pauwels, R.A. The role of neural inflammation in asthma and chronic obstructive pulmonary disease. Ann. NY Acad. Sci., 2003, 992, 218-230.
63. Boot Johan, D.; de Haas, S.; Tarasevych, S.; Roy, C.; Wang, L.; Amin, D.; Cohen J.; Sterk P.J.; Miller B.; Paccaly A.; Burggraaf J.; Cohen A.F.; Diamant Z. Effect of an NK1/NK2 receptor antagonist on airway responses and inflammation to allergen in asthma. Am. J. Crit. Care Med., 2007, 175, 450-457.